The following faculty experts available for interviews related to the novel Coronavirus outbreak. Brief descriptions of their relevant expertise are included. To arrange an interview with one of these faculty members, please contact Kelly Blake, Assistant Dean of Communications for the School of Public Health, at kellyb@umd.edu or 301-405-9418. 

You may view the recording of the Coronavirus Epidemic Symposium at which many of the following faculty experts presented on February 20 at: go.umd.edu/covid19-watch

Boris D. Lushniak, MD, MPH 
Professor and Dean
University of Maryland School of Public Health 

Dr. Lushniak is available to speak about public health preparedness and response in the United States and the historical context of lessons learned from previous pandemics.

His relevant experience includes serving in leadership roles and responding to public health emergencies including:

  • Serving as U.S. Deputy Surgeon General from November 2010 to September 2015
  • In New York at “Ground Zero” after September 11, 2001 as part of the CDC/NIOSH team
  • After the 2001 anthrax attacks in Washington, DC as part of the CDC team. 
  • Hurricane Katrina (while serving as FDA Assistant Commissioner for Counterterrorism Policy)
  • 20019 H1N1 influenza pandemic, as the FDA Deputy Incident Commander
  • ​Ebola outbreak in Liberia in 2015, as commander of the USPHS Monrovia Medical Unit, the only U.S. government hospital providing care to Ebola patients.

Sandra C. Quinn, PhD 
Professor and Chair, Department of Family Science
University of Maryland School of Public Health 

Dr. Quinn is available to speak about perceptions of risk during a pandemic, differential impacts of a pandemic on different populations (including racial/ethnic minorities), attitudes toward vaccination, trust in government and public acceptance of an emergency use authorization of a vaccine or drug during a pandemic.

Her relevant experience includes:   

  • Conducted research during previous public health emergencies including the 2001 anthrax attack and the 2009-10 H1N1 pandemic. 
  • Also conducted a study for the FDA on public understanding of medical countermeasures
  • Led first study of a conceptual model on disparities in the H1N1 pandemic that documented that those unable to social distance will bear a larger burden of disease Led first studies on public acceptance of an “emergency use authorization” of a vaccine or drug during the H1N1 pandemic and the public's ability to handle uncertainty and its impact on perceived quality of communication during the pandemic, and the impact of President Obama's public discussion of having his daughters vaccinated and more
  • Current member of the National Academies of Science, Engineering and Medicine Committee on Evidence-Based Practices for Public Health Emergency Preparedness and Response
  • Currently studying vaccine narratives on multiple social media platforms with publications related to misinformation contributed by Russian trolls and bots, etc. 
  • ​Taught and trained public health professionals on Crisis and Emergency Risk Communication.

Donald Milton, MD, DrPH 
Professor, Maryland Institute for Applied Environmental Health
University of Maryland School of Public Health 

Dr. Milton can speak about what is known about how the novel coronavirus spreads and how to best prevent transmission. He can also speak about the efficacy of using surgical masks to prevent transmission and the role of airborne transmission. He also can share insights into the challenges of developing a vaccine. 

Relevant experience: 

  • Published a study examining the effectiveness of surgical masks (2013) for controlling shedding of influenza virus into large respiratory droplets and fine particle aerosols and is a co-author of a new paper examining the impact on coronavirus shedding (under review).
  • Published a study examining how the influenza virus spreads (2018) using exhaled breath analysis, which showed that airborne transmission is more likely an important mode for influenza virus (flu) than previously thought.
  • PI of the C.A.T.C.H. (Characterizing And Tracking College Health) the Virus Study (funded by DARPA), which seeks to understand what makes people with respiratory infections contagious to help inform strategies to prevent viral transmission, including recent publication on the role of ventilation in respiratory virus transmission.
  • Led NIH, CDC, and IARPA-funded projects that developed novel exhaled breath sampling methods and for the first-time characterized aerosol shedding from people infected with influenza.

Marian Moser Jones, PhD, MPH
Associate Professor
Department of Family Science
University of Maryland School of Public Health 

Dr. Marian Moser Jones is available to speak about the historical context of public health pandemics and the response by governments. Her research and writings have focused on public health history and ethics - including the 1918-19 influenza pandemic and how and why the American institutional sector has developed to provide for the health and survival needs of families, children, and other vulnerable populations in crisis situations, as well as how it has exercised the power to decide what is best for peoples’ health and well-being. 

Dina Borzekowski, PhD
Research Professor, Behavioral and Community Health
University of Maryland School of Public Health 

The novel Coronavirus epidemic can be particularly scary to young people, whose lives are being affected by illness, cancellations, and possible school closures. Dr. Borzekowski can offer advice on how to better reach children and adolescents with important messages and provide coping skills. 
 
Relevant experience:
  • Worked with production companies, including Sesame Workshop, MTV, and the BBC, to develop media productions for children.
  • Conducted research on the impact of health messages, using randomized control trial, longitudinal, and qualitative approaches.
  • Produced videos on different health topics, including exposure to tobacco marketing, food and beverage advertising, and violent content.
  • Serves as the Interim Director of the Global Health Initiative, assisting with educational, service, and research projects in more than two dozen countries.

Hongjie Liu, PhD
Professor and Chair, Epidemiology and Biostatistics
University of Maryland School of Public Health 

Dr. Liu can speak about the features of the novel coronavirus epidemic in China and the ongoing prevention measures to contain the spread. 

Relevant experience: 

  • Published research on the control and prevention of the SARS outbreak in Hong Kong (2002-4) 
  • Expertise related to epidemiological modeling of disease spread
  • Worked as the chief epidemiologist in Anhui Provincial Center for Disease Control for 10 years
  • ​Research focuses on infectious disease epidemiology (e.g., HIV/STDs)

Muhiuddin Haider, PhD 
Clinical Professor in Global Health
University of Maryland School of Public Health

Dr. Haider can speak about public health surveillance and community-based prevention, communication in health emergencies, and the preparedness of health systems and service delivery. 

Relevant experience: 

  • Provided assistance for multi-sector initiatives to advance the delivery of quality health care services in the areas of Avian Influenza, HIV/AIDS, TB, RH/FP, Malaria and improve health communication and health education
  • Teaches undergraduate courses for Public Health Science and Global Health Scholars Programs related to strategies of behavior change and application of social marketing tools for health promotion
  • ​Has led major public health projects in several countries in Africa and Asia, for which he utilized technical skills to stimulate innovative and culturally sensitive approaches grounded in organizational and technical soundness.